Significance of serologic abnormalities in lepromatous leprosy.
D000888:Antibodies, Anti-Idiotypic / Q000032:analysis; D000974:Antibodies, Antinuclear / Q000032:analysis; D001327:Autoimmune Diseases / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis; D003165:Complement System Proteins / Q000032:analysis; D006386:Hemagglutination Tests; D006511:Hepatitis B Antigens / Q000032:analysis; D006801:Humans; D005779:Immunodiffusion; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis*; D007841:Latex Fixation Tests; D007918:Leprosy / Q000097:blood / Q000175:diagnosis / Q000276:immunology*; D010587:Phagocytosis; D012217:Rheumatoid Factor / Q000032:analysis
D000888:Antibodies, Anti-Idiotypic; D000974:Antibodies, Antinuclear; D006511:Hepatitis B Antigens; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D003165:Complement System Proteins; D002097:C-Reactive Protein; D012217:Rheumatoid Factor